A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
Clinical trial NCT01529515 · COMPLETED
Trial details
- NCT number
- NCT01529515
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2014-04-01
- Enrollment
- 509
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.